We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Agronomics Limited | LSE:ANIC | London | Ordinary Share | IM00B6QH1J21 | ORD 0.0001P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 5.65 | 5.60 | 5.70 | 5.65 | 5.59 | 5.65 | 50 | 08:00:24 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Investors, Nec | 30.88M | 22.37M | 0.0225 | 2.51 | 56.11M |
From Aug 2019 to Aug 2024
TIDMPEBI
RNS Number : 5331F
Port Erin Biopharma Investments Ltd
18 June 2012
Port Erin Biopharma Investments Limited
("Port Erin" or the "Company")
Director's Dealing
Port Erin, the AIM listed company focused on investing in the biotechnology and biopharmaceutical sectors, was informed that Galloway Limited purchased 500,000 Ordinary Shares at a price of 7 pence per share on 15 June 2012.
Galloway Limited is wholly owned by a trust in which Jim Mellon, Chairman of the Company, has a life tenancy. Denham Eke, a Director of the Company, is a director of Galloway Limited.
Following this transaction, the total Ordinary Shares in which Jim Mellon has a beneficial interest is 3,941,000, representing 11.8% of the issued ordinary share capital of the Company.
Enquiries:
Port Erin Biopharma Investments Limited Denham Eke (+44) 1624 639396 Libertas Capital Corporate Finance Limited Sandy Jamieson (+44) 20 7569 9650 Rivington Street Corporate Finance Limited John Levinson (+44) 20 7562 3350
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSKDLBFLQFLBBV
1 Year Agronomics Chart |
1 Month Agronomics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
